Stock Market News- Stocks to Watch out on 22 November 2017

sensex up Key benchmark indices edged higher in early trade on Wednesday, with indices extending fresh gains tracking steadiness in Asian stocks. The stocks of Adani Ports, Mahindra and Mahindra, Bajaj Auto, HDFC rose, while the shares of Dr. Reddy’s and Axis Bank fell in early hours. At 10.35 am, the BSE Sensex traded higher by 38.28 points to 33,514.63, while the NSE Nifty 50 rose 0.65 points to 10,327.55.

Stocks to watch out today: Steel Authority of India’s (SAIL) stock will be watched out as the company is likely to have JV for 1.5 million ton steel plant for production of auto-grade steel with Arcelor Mittal.

Telecom sector stocks will be in limelight as the Telecom Regulator has put forward relaxing spectrum holding limits.

Shares of Reliance Industries Limited is on watch after the global investment banking company Goldman Sachs raised their target price by 26% to Rs 1,205. RIL shares rose by 2% to Rs.939.65, on Tuesday’s closing.

Ajanta Pharma announced that it has got the USFDA approval for the bioequivalent generic version of Kapvay tablets and the same has been launched in US market through its wholly owned subsidiary, Ajanta Pharma USA Inc.

Bank of Baroda has announced that it has approved the proposal of raising additional equity capital aggregating upto Rs 6000 crore by way of rights issue or QIP, depending on applicable statutory approvals.

Sensex opens below 33,000, Stock Trading news and Calls on 15 November 2017

stock advisory companyThe key benchmark indices extended losses with Sensex lost 125 points to hit the day’s low of 32,816 levels while the NSE Nifty dropped 44 points to mark a day’s low of 10,142.55 at 10.45 hours on Wednesday.

Sun Pharma was the biggest loser on Sensex after the company reported a decline of 59.19% in the consolidated net profit to Rs 912.12 cr for the quarter ended on 30 Sept 2017 YoY basis.

Earnings Reports: GAIL (India)’s net profit rose 41.6% to Rs. 1309.63 Cr on 4.5% growth in net sales to Rs. 12409.65 Cr in Q2 Sept 2017 on YoY basis.

Bank of Baroda’s net profit fell 35.64% to Rs. 355.36 Cr on 3.68% rise in total income to Rs. 12490.39 Cr in Q2 Sept 2017 YoY.

Indiabulls Real Estate’s consolidated net profit fell 30.28% to Rs. 93.90 Cr on 1.54% rise in net sales to Rs. 721.58 Cr in Q2 Sept 2017 year on year.

NBCC (India)’s consolidated net profit rose 31.33% to Rs. 81.24 Cr on 12.07% fall in net sales to Rs. 1,319.25 Cr in Q2 Sept 2017 YoY.

The major companies which are lined up to announce their Q2 earnings are New India Assurance Company, CARE Ratings, Golden Tobacco, TD Power Systems, Digjam, Empee Distilleries, Automotive Axles, HMT and Universal Cables, among others.

03 Nov Sensex Nifty little high in early trade, Stocks in Focus Today

stock market high Sensex, Nifty drifted little high in early trade led by gains with the NSE Nifty rising 10.30 points or 0.10% at 10,434.10 while BSE Sensex gained 33.76 points or 0.10% to start at 33,608.98 at 10.25 am today, 3 Nov. 2017.

Bharti Airtel Ltd shares were the lead gainer on both Sensex and Nifty, jumped 3.97% to hit a fresh ten-year high of Rs. 564.8 subsequent on the Bharti Telecom acquired 4.62% stake in Bharti Airtel in a block deal.

Stock News: Punjab National Bank, Hindalco, Tata Power, Titan Watch Company and UCO Bank are among the companies that will be announcing their Q2 earnings today.

Shares of Vedanta Ltd hit a fresh 52-week high, rising its shares by 1.64% to Rs 346.4 on NSE after the company reported a 43% growth in consolidated net profit at Rs 2,036 crore for the Q2 Fy17 led by higher production and strong commodity prices.

Punjab National Bank reportedly has given its approval for partial stake sale in arm PNB Housing Finance and entire stake sale in Principal PNB AMC.

AU Small Finance Bank has got sanction from RBI to operate as Scheduled Commercial Bank. Its name has already been enrolled in the Second Schedule of RBI Act, 1934. 

Dr Reddy’s Laboratories has announced that it has launched generic Azacitidine for injection, a cancer treatment drug, in the markets at Canada.